Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015
Go back to Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015| Amgen Inc (NASDAQ: AMGN) | Delayed: 347.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $347.01 | 52 Week High | $176.85 | |||
| Open | $347.01 | 52 Week Low | $133.64 | |||
| Day High | $347.01 | P/E | 52.26 | |||
| Day Low | $347.01 | EPS | $6.64 | |||
| Volume | 1,279 | |||||

